LENZ THERAPEUTICS, INC. Cash and Restricted Cash
LENZ THERAPEUTICS, INC. (LENZ) had Cash and Restricted Cash of $25.18 million as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-24
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25.18M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25.40M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $37.72M.
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23.16M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $25.18M 10-K · filed 2026-03-24 |
| 2025-09-30 | $25.40M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $37.72M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $23.16M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $20.27M 10-K · filed 2026-03-24 |
| 2024-09-30 | $41.16M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $84.15M 10-Q · filed 2025-07-30 |
| 2024-03-31 | $200.47M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $35.14M 10-K · filed 2026-03-24 |
| 2023-09-30 | $42.85M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $74.42M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $114.82M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $44.44M 10-K · filed 2025-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |